Immunomedics, Inc. announced that in accordance with the Merger Agreement, at the effective time of the Merger, Behzad Aghazadeh resigned as Executive Chairman and from the board of directors of the Company, and each of Robert Azelby, Charles Baum, Scott Canute, Barbara Duncan, Peter Barton Hutt and Khalid Islam resigned from the board of directors of the Company. These resignations were in connection with the Merger and not as a result of any disagreements between the Company and the resigning individuals on any matters relating to the Company's operations, policies or practices. Andrew D. Dickinson assumed the roles of director and President and Treasurer of the Company, Brett A. Pletcher assumed the roles of director and Secretary of the Company and Christina Carlson assumed the roles of director and Assistant Secretary of the Company.